Clinical Trial Update: Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating recombinant Factor VIIa for intracerebral hemorrhage, with the study currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Recombinant Factor VIIa (rFVIIa) (recombinant coagulation factor VIIa)

Snippet

Sponsor: Joseph Broderick, MD | Conditions: Intracerebral Hemorrhage | Phase 3 | Status: RECRUITING